IL6 and nasopharyngeal carcinoma: To confirm whether HMGB1 contributes to cisplatin resistance in NPC cells via targeting IL6 directly, we established HMGB1 knock-out cells in resistant NPC cells (CNE-2 CR KO) for rescue experiments (Figures 4A, B).